Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Biomarkers / OPCML

OPCML

Basics

Aliases:
This biomarker is also known as:
  • opioid binding protein/cell adhesion molecule-like preprotein,
  • IgLON family member 1,
  • OPCM,
  • opioid-binding protein/cell adhesion molecule-like,
  • OBCAM,
  • Opioid-binding cell adhesion molecule,
  • opioid binding protein/cell adhesion molecule-like,
  • IGLON1,
  • opioid-binding protein/cell adhesion molecule,

View in BioMuta

Description…

The OPCML protein is a member of the IgLON subfamily in the immunoglobulin protein superfamily. OPCML binds opioids in the presence of acidic lipids. The gene has an ortholog in rat and bovine. The OPCML protein is highly conserved across species, and therefore it is hypothesized that it may have a fundamental role in mammalian systems. There are two different isoforms, each from its own transcript.

Attributes

QA State: Under Review
Type: Gene
Short Name:
HGNC Name: OPCML

Datasets

There are no datasets associated with this biomarker.

Organs

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Studies

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Publications

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Resources

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

2015 EDRN PI Orientation

The New and Continuing EDRN Principal Investigator Orientation will take place October 15–16, 2015 in Bethesda, Maryland.

Announcement 06/30/2015

A funding opportunity for a new pancreatic cancer initiative, called The Pancreatic Cancer Detection Consortium (U01), has been released. For more information, please go to http://grants.nih.gov /grants/guide/ pa-files/ PAR-15-289.html.

Announcement 04/08/2015

Thank you to everyone who made the 29th EDRN Steering Committee Meeting a success. The orientation for new and continuing EDRN PIs will be held October 15-16, 2015 on the NCI campus. More information will be available later this summer.